Leflunomide Treatment Does Not Protect Neural Cells following Oxygen-Glucose Deprivation (OGD) In Vitro

Claire J. M. Curel & Claire Thornton et al. · 2024

3Citations
Links
TL;DR

Treating C17.2 cells with Leflunomide before or after oxygen-glucose deprivation to determine its efficacy as a neuroprotection and inhibitor of mitochondrial dysfunction confirmed that the tissue and mitochondrial protein profile of the target cell/tissue are critical for taking advantage of the therapeutic actions of Leflunomide.

AI-generated by Semantic Scholar

Authors
Claire J. M. Curel, Irene Nobeli, Claire Thornton